https://doi.org/10.4081/monaldi.2025.3173
Dilated cardiomyopathy - guidelines for personalization of care
Submitted: August 6, 2024
Accepted: January 30, 2025
Published: April 1, 2025
Accepted: January 30, 2025
Abstract Views: 126
PDF: 65
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The term dilated cardiomyopathy (DCM) refers to a family of diseases characterized by complex interactions between environment and genetic predisposition. Diagnostic tools such as cardiac magnetic resonance imaging should be systematically implemented in clinical practice to define the etiological cause and undertake a specific treatment. We present the case of a young man with DCM and severe left ventricular dysfunction. The patient has a family history of sudden cardiac death (SCD). He is affected by a psychiatric pathology and has a history of alcohol and drug addiction. Many diagnostic hypotheses have been considered for etiological research. The use of a wearable defibrillator to temporarily protect the patient from SCD risk pending the completion of the diagnostic path to establish DCM etiology and the implementation of optimal medical therapy was considered. However, because of the underlying psychiatric pathology and the possibility of poor adherence to the maintenance of the wearable device, the patients would not have been sufficiently protected. Due to the young age of the patient, it was decided to make a personalized therapeutic choice, and he underwent implantation of a subcutaneous defibrillator.
Arbelo E, Protonotarios A, Gimeno JR, et al. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J 2023;44:3503-626.
DOI: https://doi.org/10.1093/eurheartj/ehad194
Lei Z, Cao J, Wu J, Lu Y, et al. Identification of the communal pathogenesis and immune landscape between viral myocarditis and dilated cardiomyopathy. ESC Heart Fail 2024;11:282-92.
DOI: https://doi.org/10.1002/ehf2.14585
Orphanou N, Papatheodorou E, Anastasakis A. Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments. Heart Fail Rev 2022;27:1173-91.
DOI: https://doi.org/10.1007/s10741-021-10139-0
Merlo M, Cannatà A, Gobbo M, et al. Evolving concepts in dilated cardiomyopathy. Eur J Heart Fail 2018;20:228-39.
DOI: https://doi.org/10.1002/ejhf.1103
William Bracamonte-Baran, Daniela Čiháková. Cardiac autoimmunity: myocarditis. Adv Exp Med 2017;1003:187-221.
DOI: https://doi.org/10.1007/978-3-319-57613-8_10
Ekström K, Lehtonen J, Kandolin R, et al. Long-term outcome and its predictors in giant cell myocarditis. Eur J Heart Fail 2016;18:1452-8.
DOI: https://doi.org/10.1002/ejhf.606
D'Ambrosio A, Patti G, Manzoli A, et al. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 2001;85:499-504.
DOI: https://doi.org/10.1136/hrt.85.5.499
Yamada T, Nomura S. Recent findings related to cardiomyopathy and genetics. Int J Mol Sci 2021;22:12522.
DOI: https://doi.org/10.3390/ijms222212522
Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur Heart J 2007;28:3076-93.
DOI: https://doi.org/10.1093/eurheartj/ehm456
Könemann H, Dagres N, Merino JL, et al. Spotlight on the 2022 ESC guideline management of ventricular arrhythmias and prevention of sudden cardiac death: 10 novel key aspects. Europace 2023;25:euad091.
DOI: https://doi.org/10.1093/europace/euad091
Fernández-Solà J. The effects of ethanol on the heart: alcoholic cardiomyopathy. Nutrients 2020;22:572.
DOI: https://doi.org/10.3390/nu12020572
Domínguez F, Adler E, García-Pavía P. Alcoholic cardiomyopathy: an update. Eur Heart J 2024;45:2294-305.
DOI: https://doi.org/10.1093/eurheartj/ehae362
Torres-Acosta N, O'Keefe JH, O'Keefe CL, Lavie CJ. Cardiovascular effects of ADHD therapies: JACC review topic of the week. J Am Coll Cardiol 2020;76:858-66.
DOI: https://doi.org/10.1016/j.jacc.2020.05.081
Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2022;43:3997-4126.
DOI: https://doi.org/10.1093/eurheartj/ehac699
Casolo G, Gulizia MM, Aschieri D, et al. Position paper ANMCO: guida all’uso appropriato del defibrillatore indossabile nella pratica clinica per i pazienti ad elevato rischio transitorio di morte improvvisa. G Ital Cardiol 2023;24:394-411. [Article in Italian].
Mc Donagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599-726.
DOI: https://doi.org/10.1093/eurheartj/ehab368
Boriani G, Vitolo M, Leyva F. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: what are the barriers to implementation in the 'real world'? Eur J Heart Fail 2022;24:1223-6.
DOI: https://doi.org/10.1002/ejhf.2581
Probst V, Boveda S, Sadoul N et al. Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: a French expert position paper. Arch Cardiovasc Dis 2020;113:359-66.
DOI: https://doi.org/10.1016/j.acvd.2020.03.011
Migliore F, Mattesi G, Zorzi A, et al. Il defibrillatore sottocutaneo nella pratica clinica G Ital Cardiol 2019;20:641-50. [Article in Italian].
Holtstiege V, Meier C, Bietenbeck M, et al. Clinical experience regarding safety and diagnostic value of cardiovascular magnetic resonance in patients with a subcutaneous implanted cardioverter/defibrillator (S-ICD) at 1.5 T. J Cardiovasc Magn Reson 2020;22:35.
DOI: https://doi.org/10.1186/s12968-020-00626-y
How to Cite
Spinelli, Antonella, Gaetano Marino, Alfredo Macchiusi, Stefania Angela Di Fusco, Carlo Pignalberi, and Furio Colivicchi. 2025. “Dilated Cardiomyopathy - Guidelines for Personalization of Care”. Monaldi Archives for Chest Disease, April. https://doi.org/10.4081/monaldi.2025.3173.
Copyright (c) 2025 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Nitesh Gupta, A J Mahendran, Shibdas Chakrabarti, Sumita Agrawal, Microscopic polyangiitis in a case of silica exposure: a rare presentation , Monaldi Archives for Chest Disease: Vol. 89 No. 3 (2019)
- Pompilio Faggiano, Francesco Fattirolli, Anna Frisinghelli, Lucrezia Piccioli, Nicolò Dasseni, Maria Vittoria Silverii, Laura Albricci, Giuseppe D'Ambrosio, Rosaria Garrì, Luigi Esposito, Francesco Giallauria, Secondary prevention advices after cardiovascular index event: From drug prescription to risk factors control in real world practice , Monaldi Archives for Chest Disease: Vol. 89 No. 2 (2019)
- Raffaele Martone, Niccolò Marchionni, Francesco Cappelli, Heart failure with mid-range ejection fraction: Current evidence and uncertainties , Monaldi Archives for Chest Disease: Vol. 89 No. 1 (2019)
- Nikoloz Koshkelashvili, Mauricio Jalife Bucay, Igor Goykhman, Gregg S. Pressman, Aortic root and valve proportions: an example of the golden ratio? , Monaldi Archives for Chest Disease: Vol. 89 No. 2 (2019)
- Agathi Spiropoulou, Nicholas Zareifopoulos, Aggeliki Bellou, Konstantinos Spiropoulos, Lazaros Tsalikis, Review of the association between periodontitis and chronic obstructive pulmonary disease in smokers , Monaldi Archives for Chest Disease: Vol. 89 No. 1 (2019)
- Iqbal Akhtar Khan, Paola Pierucci, Nicolino Ambrosino, COPD patients’ pre-flight check: A narrative review , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
- Emel Cireli, Aydan Mertoğlu, The impact of anemia on the mortality of COPD patients hospitalized for acute exacerbation resulting in respiratory failure , Monaldi Archives for Chest Disease: Vol. 93 No. 2 (2023)
- Rajesh Venkataram, Vijith Shetty, Kishan Prasad, Sonam Kille, Teerthanath Srinivas, Anirban Chakraborty, Detection of clinically-relevant EGFR variations in de novo small cell lung carcinoma by droplet digital PCR , Monaldi Archives for Chest Disease: Vol. 93 No. 2 (2023)
- Ravi Manglani, Sara Akbar, Mary Beth Beasley, Oleg Epelbaum, A 44-year-old stone worker with progressive dyspnea: lessons from a new twist on an old foe , Monaldi Archives for Chest Disease: Vol. 93 No. 2 (2023)
- Dario Amore, Marco Rispoli, Umberto Caterino, Dino Casazza, Pasquale Imitazione, Alessandro Saglia, Cristiano Cesaro, Comments on “The surgical approach of late-onset tracheoesophageal fistula in a tracheostomized COVID-19 patient” , Monaldi Archives for Chest Disease: Vol. 94 No. 3 (2024)
You may also start an advanced similarity search for this article.
